Tag: venous thromboembolism

haemodialysis

Arteriovenous graft use linked to venous thromboembolism risk in haemodialysis patients

In an observational cohort study of Medicare beneficiaries receiving haemodialysis, the use of an arteriovenous graft (AVG) compared with an arteriovenous fistula (AVF) was...

Michael Cerminaro to succeed Marvin Woodall as CEO of Thrombolex

Thrombolex has announced that its board of directors has named Michael Cerminaro chief executive officer (CEO) effective 13 July 2022, the date of the...
Cordis

Cordis makes strategic investment in E2, a developer of next-generation thrombectomy...

Cordis has announced a strategic investment venture that will expand the scope of the global cardiovascular technology company into the venous thromboembolism (VTE) market...

Prolonged TV watching may increase risk of venous thromboembolism

A new study reports that watching TV for four hours a day or more is associated with a 35% higher risk of venous thromboembolism...

BTG acquires Novate Medical

BTG has announced it has acquired Novate Medical, a medical device company focused on the prevention of pulmonary embolism in patients at high risk...

First patient enrolled in Daiichi Sankyo European edoxaban registry

The first patient has been enrolled in Daiichi Sankyo’s EMIT-AF/VTE (Edoxaban Management in Diagnostic and Therapeutic Procedures) study. This registry will collect real-world clinical...